SWI5 Antibody

What is the biological function of SWI5 across different species?

SWI5 exhibits diverse functions depending on the organism. In yeast, SWI5 functions as a transcription factor controlling the expression of genes including SIC1, EGT2, CDC6, and RME1 . In fission yeast (S. pombe), SWI5 participates in DNA recombination repair, specifically in the Rhp51-dependent recombination repair pathway . This function differs significantly from its role in budding yeast. In mammalian cells, SWI5 forms a complex with Sfr1 that plays a crucial role in homologous recombination (HR), which is essential for DNA strand break repair and maintenance of genomic integrity . Additionally, SWI5 interacts with the Mediator complex in transcriptional regulation through specific interactions with components like Gal11 . These diverse functions highlight the evolutionary adaptability of SWI5 across different organisms.

How is SWI5 regulated at the protein level?

SWI5 protein levels are tightly regulated through multiple mechanisms. In yeast, SWI5 becomes particularly unstable during the G1 phase of the cell cycle . This instability is mediated through the ubiquitin-proteasome pathway, with SWI5 being a substrate of the SCFCdc4 ubiquitin ligase complex . Phosphorylation plays a critical role in this process, as demonstrated by experiments showing that a phosphorylation-deficient Swi5-ST8A mutant exhibited diminished ubiquitination . In mammalian cells, SWI5 demonstrates protein stability interdependence with its binding partner Sfr1, where the absence of either protein affects the stability of the other . This suggests that complex formation protects both proteins from degradation. Researchers investigating SWI5 regulation should consider these mechanisms when designing experiments, particularly when studying protein turnover or stability under different cellular conditions.

What experimental evidence established SWI5's role in DNA repair?

The involvement of SWI5 in DNA repair has been established through several key experimental approaches. In fission yeast, genetic studies demonstrated that swi5Δ rhp51Δ double mutants exhibited the same sensitivity to DNA-damaging agents (γ-rays, UV irradiation, and methyl methanesulfonate) as rhp51Δ single mutants, indicating that swi5 is epistatic with rhp51 and functions in Rhp51-dependent recombination repair . Furthermore, overexpression of Rhp51 partially suppressed the DNA repair defects of swi5Δ mutants, suggesting functional interaction between these proteins . Additional genetic evidence showed that swi5Δ rhp57Δ double mutants were more sensitive to DNA damage than either single mutant, indicating that SWI5 functions in a parallel pathway to Rhp57 in Rhp51-dependent DNA repair . In mammalian systems, SWI5-deficient mouse ES cell lines demonstrated hypersensitivity to DNA-damaging agents, confirming conservation of this function across species . These multiple lines of experimental evidence firmly establish SWI5's critical role in DNA repair mechanisms.

What methods are used to generate effective SWI5 antibodies?

The generation of effective SWI5 antibodies typically involves a multi-step process that begins with recombinant protein production. According to published protocols, full-length SWI5 cDNA is cloned into expression vectors such as pET15b to produce His6-tagged SWI5 protein in E. coli (specifically BL21-Codonplus DE3 strains) . The recombinant protein is then purified using affinity chromatography methods like TALON (Clontech) to obtain a pure immunogen . For polyclonal antibody production, the purified His6-tagged SWI5 is used to immunize animals (typically rabbits), and the resulting antisera are collected after sufficient immunization periods . Critical to obtaining high-quality antibodies is the subsequent affinity purification step, where the crude antisera are purified against the recombinant protein to isolate SWI5-specific antibodies and remove non-specific antibodies . This methodology has been successfully used to generate mouse SWI5 antibodies that function effectively in multiple applications including Western blotting, immunoprecipitation, and immunofluorescence studies.

How should researchers validate the specificity of SWI5 antibodies?

Validation of SWI5 antibody specificity requires a multi-faceted approach to ensure reliable experimental results. The gold standard validation method involves using genetic knockout controls, such as SWI5-deficient cell lines, to confirm antibody specificity . In published studies, SWI5-/- mouse ES cell lines were used to confirm complete absence of signal in Western blotting and immunofluorescence, providing definitive evidence of antibody specificity . Domain mapping experiments offer another validation approach, where truncated versions of SWI5 (such as His6-SWI5(1-709) versus His6-SWI5(539-681)) can determine which epitopes are recognized by the antibody . Researchers should also verify that the antibody detects proteins of the expected molecular weight and subcellular localization (SWI5 is primarily nuclear) . Cross-reactivity testing across species is important when working with SWI5 from multiple organisms, as sequence conservation may be limited. Additionally, competing experiments with blocking peptides (the original immunizing antigen) can further confirm specificity by abolishing antibody binding. Implementing these validation methods ensures that experimental results with SWI5 antibodies are reliable and reproducible.

What considerations are important when selecting SWI5 antibodies for cross-species studies?

When selecting SWI5 antibodies for cross-species studies, researchers must carefully consider several critical factors. First, sequence divergence between species is substantial - SWI5 proteins from budding yeast, fission yeast, and mammals show limited sequence conservation, particularly outside functional domains . This divergence necessitates species-specific antibodies in most cases. Second, domain conservation analysis should guide antibody selection, as certain domains (such as DNA-binding regions or interaction interfaces) may be more conserved than others. The search results indicate that coiled-coil motifs in SWI5 that mediate protein interactions may be better conserved than other regions . Third, researchers must consider functional homology versus sequence homology, as proteins with similar names may have different functions across species - yeast SWI5 functions primarily as a transcription factor , while mammalian SWI5 is mainly involved in DNA repair . Finally, epitope accessibility may differ between species due to divergent post-translational modifications or protein interactions. When possible, researchers should validate antibody cross-reactivity empirically by testing against recombinant proteins or extracts from multiple species before conducting cross-species comparisons.

What is the optimal protocol for SWI5 co-immunoprecipitation experiments?

The optimal protocol for SWI5 co-immunoprecipitation involves several carefully optimized steps to maintain protein interactions while minimizing background. According to published methods, cells should first be lysed in buffer containing 50 mM Tris-HCl (pH 8.0), 2 mM EDTA, 125 mM NaCl, 1% NP-40, complete protease inhibitor cocktail, and phosphatase inhibitors . This lysis buffer composition is critical for maintaining protein interactions while effectively solubilizing membrane-associated proteins. Following lysis, cell extracts should be incubated on ice for 20 minutes, then centrifuged at 15,000 × g for 20 minutes to remove insoluble material . For the immunoprecipitation step, SWI5 antibodies should be added to approximately 200 μg of protein extract and incubated for 2 hours at 4°C to allow antibody-antigen binding . Protein G Dynabeads are then added and incubated for an additional hour to capture the antibody-antigen complexes . A rigorous washing procedure follows, consisting of six washes with buffer containing 50 mM Tris-HCl (pH 8.0), 2 mM EDTA, 200 mM NaCl, and 1% NP-40 . The higher salt concentration in the wash buffer (200 mM versus 125 mM in lysis buffer) helps reduce non-specific binding. Finally, immunoprecipitated proteins are eluted by boiling in SDS-PAGE sample buffer and analyzed by Western blotting . This protocol has successfully demonstrated interactions between SWI5 and proteins like Sfr1 in mammalian cells.

How can researchers detect weak or transient SWI5 protein interactions?

Detecting weak or transient SWI5 protein interactions requires specialized approaches, as standard immunoprecipitation may fail to capture these interactions. The search results specifically note that interactions between SWI5, Sfr1, and Rhp51 can be "very weak and/or transient in vivo" . To overcome this challenge, researchers should implement several strategies. First, consider in vivo crosslinking with membrane-permeable crosslinkers like formaldehyde or DSP (dithiobis(succinimidyl propionate)) to stabilize transient interactions before cell lysis. Second, optimize buffer conditions by reducing salt concentration or using more gentle detergents to preserve weak interactions. Third, employ complementary in vitro techniques such as GST pull-down assays, which have successfully detected SWI5 interactions that were not observable by co-immunoprecipitation alone . Fourth, consider alternative genetic approaches like yeast two-hybrid assays, which have proven valuable for identifying SWI5 interaction partners . Finally, researchers might explore proximity-based labeling techniques (though not mentioned in the search results) such as BioID or APEX, which can capture even very transient interactions by labeling proteins in close proximity to SWI5 in living cells. A multi-method approach is often necessary to comprehensively characterize the SWI5 interactome, especially for interactions that may be physiologically important but biochemically challenging to detect.

What techniques can be used to study SWI5 chromatin association and transcriptional activity?

Studying SWI5's chromatin association and transcriptional activity requires specialized techniques that capture its DNA binding and recruitment of transcriptional machinery. The search results indicate that SWI5 functions as a transcription factor controlling specific genes and interacts with the Mediator complex and SWI/SNF chromatin remodeling complex , suggesting several appropriate methodological approaches. Chromatin immunoprecipitation (ChIP) using SWI5 antibodies can identify genomic binding sites, though specific ChIP protocols were not detailed in the search results. Co-immunoprecipitation experiments have successfully demonstrated interactions between SWI5 and transcriptional machinery components, including Mediator subunits (Gal11-Myc, Srb4-Myc) and SWI/SNF components (Swi2-Myc) . The interaction between SWI5 and the Mediator complex was further validated using an in vitro pull-down approach where purified His6-SWI5 was incubated with yeast extracts and interactions were detected by immunoblotting . To study SWI5's recruitment of transcriptional machinery to specific promoters, researchers have used truncated versions of SWI5 (such as His6-SWI5(539-681), which contains the DNA-binding domain but lacks protein interaction regions) to dissect domain-specific functions . Sequential ChIP (Re-ChIP) would be another valuable approach to determine co-occupancy of SWI5 with transcriptional machinery components, though this was not explicitly mentioned in the search results.

How do SWI5-Sfr1 interactions contribute to DNA repair mechanisms?

The SWI5-Sfr1 complex plays a crucial role in homologous recombination-mediated DNA repair through specific interactions with recombination machinery. Experimental evidence from both yeast and mammalian systems has elucidated the molecular basis of this function. In fission yeast, genetic studies established that SWI5 functions in a DNA repair pathway parallel to but distinct from the Rhp57-dependent pathway . Both pathways converge on Rhp51 (the fission yeast homolog of mammalian RAD51), a key recombinase in homologous recombination . Physical interaction studies including yeast two-hybrid assays, co-immunoprecipitation, and GST pull-down experiments have demonstrated that SWI5 forms a complex with Sfr1, and this complex can interact with Rhp51 . Domain mapping experiments revealed that the N-terminal half of SWI5 interacts with the C-terminal region of Sfr1, with both interaction domains containing coiled-coil motifs that likely mediate the interaction . In mammalian cells, the SWI5-Sfr1 complex has been shown to be critical for DNA strand break repair, with knockout studies in mouse ES cells confirming this function . The interaction appears to be highly conserved despite limited sequence conservation, suggesting strong evolutionary pressure to maintain this DNA repair mechanism . Importantly, SWI5 and Sfr1 demonstrate mutual protein stability dependence, indicating that complex formation is required for function .

How can researchers distinguish between SWI5's roles in transcription versus DNA repair?

Distinguishing between SWI5's roles in transcription versus DNA repair requires careful experimental design that separates these potentially overlapping functions. Based on the search results, several approaches can effectively differentiate these functions. First, domain-specific mutations or truncations can separate functional roles - the DNA-binding domain of SWI5 (residues 539-681 in one construct) is essential for transcriptional regulation , while the N-terminal region interacts with Sfr1 for DNA repair functions . Second, context-specific protein interactions provide functional distinction - SWI5 interacts with Mediator complex components (Gal11) and SWI/SNF (Swi2) in transcriptional contexts , but with Sfr1 and Rhp51/Rad51 in DNA repair contexts . Third, cell cycle-dependent analysis can differentiate these functions, as SWI5's stability changes during the cell cycle, becoming particularly unstable in G1 phase , potentially affecting its availability for different functions. Fourth, researchers should consider species-specific functions, as SWI5's primary role appears to be transcriptional regulation in budding yeast but DNA repair in fission yeast and mammals . Finally, functional readouts can provide clear distinction - measuring transcriptional activity of target genes versus DNA repair efficiency following damage in various SWI5 mutant backgrounds. By implementing these approaches, researchers can effectively dissect SWI5's dual functionality in cellular processes.

What experimental approaches can elucidate the mechanism of SCFCdc4-mediated degradation of SWI5?

Elucidating the mechanism of SCFCdc4-mediated degradation of SWI5 requires several specialized experimental approaches focused on ubiquitination and proteasomal degradation pathways. The search results describe a refined two-hybrid system specifically designed to identify F-box protein-substrate interactions that might otherwise be difficult to detect due to rapid substrate degradation . This specialized system allowed researchers to identify SWI5 as a substrate of the SCFCdc4 complex . To directly demonstrate SWI5 ubiquitination in vivo, researchers utilized several sophisticated approaches. They employed pdr5Δ yeast mutants, which are permeable to the proteasome inhibitor MG132, to allow accumulation of ubiquitinated proteins . They expressed SWI5-HA from a GAL1 promoter along with a hexahistidine- and MYC-tagged mutant ubiquitin (K48R, G76A) from a CUP1 promoter . Since SWI5 becomes unstable specifically in G1 phase, they synchronized cells in G1 using α-factor treatment . The ubiquitinated SWI5 was then isolated and detected through nickel affinity purification and western blotting . The importance of phosphorylation in this process was demonstrated using a phosphorylation-deficient SWI5-ST8A mutant, which showed diminished ubiquitination . The functional role of Cdc4 was confirmed by examining SWI5 ubiquitination in cdc4-1 temperature-sensitive mutants, where ubiquitination was markedly decreased . These approaches collectively provide a methodological framework for studying regulated proteolysis of transcription factors.

What strategies can overcome low signal issues when detecting SWI5 in immunoblotting experiments?

Overcoming low signal issues when detecting SWI5 in immunoblotting experiments requires systematic optimization of multiple parameters. Based on the search results and standard immunoblotting practices, researchers should consider several targeted approaches. First, optimize protein extraction conditions, as SWI5 may have limited solubility or be present in specific subcellular compartments. The search results describe specific lysis buffer compositions (50 mM Tris-HCl, pH 8.0, 2 mM EDTA, 125 mM NaCl, 1% NP-40 with protease and phosphatase inhibitors) that successfully extracted SWI5 . Second, address protein stability concerns - the search results indicate that SWI5 is unstable in certain conditions, particularly during G1 phase in yeast , and that SWI5 and Sfr1 exhibit mutual stability dependence . Consider treating cells with proteasome inhibitors like MG132 before lysis to prevent degradation . Third, increase protein concentration by using immunoprecipitation to enrich SWI5 before immunoblotting, as demonstrated in co-IP protocols from the search results . Fourth, optimize antibody conditions by testing different antibody concentrations, incubation times, and blocking reagents. Fifth, consider signal enhancement methods such as more sensitive chemiluminescence substrates or fluorescently-labeled secondary antibodies for detection. Finally, if genomic expression levels are too low for detection (as observed with some SWI5-interacting proteins ), consider using overexpression systems with stronger promoters as a strategy to validate antibody performance before attempting to detect endogenous proteins.

How should researchers address inconsistent results in SWI5 interaction studies?

Inconsistent results in SWI5 interaction studies can arise from multiple sources and require systematic troubleshooting approaches. The search results highlight several key challenges that may contribute to variability. First, consider the transient nature of interactions - the papers explicitly state that interactions between SWI5, Sfr1, and Rhp51 may be "very weak and/or transient in vivo" , explaining why certain interactions were detected by some methods but not others. To address this, implement multiple complementary techniques (co-IP, yeast two-hybrid, GST pull-down) as demonstrated in the search results . Second, evaluate buffer compatibility issues - different lysis and binding conditions can dramatically affect interaction stability. The search results detail specific buffer compositions that successfully maintained interactions . Third, assess cellular context variations - interactions may be cell cycle-dependent, damage-induced, or affected by growth conditions. SWI5 becomes specifically unstable in G1 phase , potentially affecting interaction studies. Fourth, consider post-translational modifications - SWI5 phosphorylation affects its ubiquitination and possibly its interactions . Fifth, examine protein expression level issues - some interaction partners may be expressed at very low levels, requiring overexpression for detection, as noted for Swi2 . Finally, validate all reagents thoroughly, particularly antibody specificity, using appropriate controls including knockout cell lines as described in the search results . By systematically addressing these potential sources of variability, researchers can achieve more consistent results in SWI5 interaction studies.

What methodological considerations are important when studying SWI5 in different model organisms?

When studying SWI5 across different model organisms, researchers must account for several critical methodological differences to ensure proper experimental design and interpretation. First, consider functional divergence - despite sharing the same name, SWI5 functions primarily as a transcription factor in budding yeast , while in fission yeast and mammals, it plays a major role in DNA repair . These distinct functions require different experimental readouts and assays. Second, account for protein interaction network differences - SWI5 interacts with the Mediator complex and SWI/SNF in budding yeast , but forms complexes with Sfr1 and Rhp51/Rad51 in fission yeast and mammals . Third, develop species-specific antibodies - due to limited sequence conservation, antibodies raised against SWI5 from one species may not recognize the protein in other species. The search results describe specific approaches for generating antibodies against mouse SWI5 . Fourth, adapt experimental conditions for each system - the search results detail different lysis buffer compositions, immunoprecipitation protocols, and growth conditions for yeast versus mammalian cells . Fifth, consider genetic manipulation differences - knockout strategies, complementation approaches, and genetic interaction studies differ significantly between yeast and mammalian systems, as exemplified by the different approaches to creating SWI5-deficient strains . Finally, implement appropriate controls specific to each model system, including species-matched knockout cells or strains as described for both yeast and mammalian systems in the search results .